Harmony Biosciences gets FDA nod for Wakix

15:09 EDT 15 Aug 2019 | Drug Store News

Wakix is the first and only non-scheduled treatment approved for patients with narcolepsy that is not scheduled as a controlled substance by the Drug Enforcement Administration, the company said. 

Read More

Original Article: Harmony Biosciences gets FDA nod for Wakix


More From BioPortfolio on "Harmony Biosciences gets FDA nod for Wakix"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...